The company aims to develop, operate and market digital health technologies, particularly software applications based on artificial intelligence, with a focus on the digitalization of clinical assessments, the automation of medical and therapeutic reports, and the support of personalized therapy planning. The company may also provide related services, particularly consulting, training, education, and research in the field of healthcare and medical technology. The company may establish branches and subsidiaries in Switzerland and/or abroad and participate in other companies in Switzerland and/or abroad, acquire, hold, encumber, and dispose of real estate or intangible assets in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, either for a fee or free of charge, and provide security for the liabilities of such persons or group companies in any form, including guarantees, pledges, and fiduciary transfers of the company's assets. In addition, it may engage in or participate in liquidity balancing/net liquidity centralization (cash pooling) with group companies, including periodic balance adjustments (balancing), without consideration, on preferential terms, interest-free, without the intention of making a profit for the company, and assuming clustering risks.